Target intelligence / Profile preview

Sudan ebolavirus matrix protein VP40 (VP40)

Target
VP40
Molecular classification
Viral matrix protein, RNA-binding protein, Peripheral membrane protein, Ribonucleoprotein
01

Overview

Sudan ebolavirus matrix protein VP40 is the primary structural protein of the Sudan virus (SUDV), a member of the Filoviridae family that causes severe and often fatal hemorrhagic fever [3, 7, 8]. As the most abundantly expressed protein during infection, VP40 is essential for the viral life cycle, coordinating the assembly and budding of new virions at the host cell plasma membrane [4, 11, 13]. It is a multifunctional protein that transitions between different oligomeric states—including dimers, hexamers, and octamers—to regulate distinct processes such as viral transcription, RNA replication, and particle morphogenesis [3, 8, 12]. Beyond its structural role, VP40 contributes to viral pathogenesis by suppressing host innate immune responses and triggering pro-inflammatory signaling through the activation of NF-κB [1, 3, 9]. Because of its critical role in viral egress and its relatively conserved structure, VP40 is considered a high-priority target for the development of novel antiviral drugs, with research focusing on small molecules that disrupt its oligomerization, membrane binding, or interactions with host cellular machinery like the ESCRT complex [4, 6, 14, 17].

Other names
Matrix protein VP40VP40Viral protein 40 kDaSUDV VP40
02

Mechanism of action

Inhibition of viral budding, assembly, and VP40 oligomerization; disruption of membrane binding and host ESCRT complex interactions [4, 6, 12].

03

Biological functions

Viral assemblyViral buddingRegulation of viral transcriptionRegulation of RNA replicationInhibition of host innate immune responseInduction of pro-inflammatory responseMorphogenesis
04

Disease associations

Sudan virus diseaseEbola virus diseaseHemorrhagic feverInfection
05

Safety considerations

Potential cytotoxicity due to interference with host ESCRT pathwaysViral resistance through protein overproductionChallenges in targeting lipid-binding domainsHigh mutation rate of RNA viruses
06

Interacting drugs

Vinblastine

11 more in the full profile.

07

Biomarkers

Virus-like particles (VLPs)Viral load (SUDV RNA)Pro-inflammatory cytokines (e.g., TNF-alpha, IL-6)Anti-VP40 antibodies

Beyond the preview

Go deeper on Sudan ebolavirus matrix protein VP40 (VP40).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sudan ebolavirus matrix protein VP40 (VP40).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call